Author

A. Hakam

Observed names: A HAKAM, A Hakam

Institutions: University of South Florida, Moffitt Cancer Center

Observed institutions: King Edward Medical University, University of South Florida, Moffitt Cancer Center

OpenAlex ID: A5113666899

Bladder cancer-associated nuclear matrix proteins.

1996 · R H Getzenberg, B R Konety, et al. · PubMed · 166

Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma

2016 · K. Matsuo, Y. Takazawa, et al. · Annals of Oncology · 111

In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival

2012 · E Bicaku, Y Xiong, et al. · British Journal of Cancer · 41

Cyclooxygenase-2 (COX-2) expression in human endometrial carcinoma and precursor lesions and its possible use in cancer chemoprevention and therapy.

2007 · A Nasir, D Boulware, et al. · PubMed · 29

Value of multilevel sectioning for improved detection of micrometastases in sentinel lymph nodes in invasive squamous cell carcinoma of the vulva.

2004 · A Hakam, A Nasir, et al. · PubMed · 26

Significance of Fas receptor protein expression in epithelial ovarian cancer

2005 · J REED, A HAKAM, et al. · Human Pathology · 15

Pelvic squamous cell carcinoma of unknown primary: a case report and review of the literature.

2016 · R Ahdallah, B Morse, et al. · PubMed · 4

Unique molecular portraits of ovarian cancer: Implications for prognostics and targeted therapeutics

2015 · B.R. Khulpateea, D. Marchion, et al. · Gynecologic Oncology · 1

Identifying drug repurposing opportunities to target genes and molecular pathways associated with cancer cell proliferation

2013 · I. Ramirez, D. Marchion, et al. · Gynecologic Oncology · 1

Molecular characterization of polyphyllin D, a Chinese herb that sensitizes ovarian cancers cells to platinum therapy

2013 · E. Al Sawah, D. Marchion, et al. · Gynecologic Oncology · 1

PLAC1 expression in human cancer cells correlates with carboplatin sensitivity and overall survival from ovarian cancer

2012 · N. Bou Zgheib, Y. Xiong, et al. · Gynecologic Oncology · 1

AKT survival signaling and phospho-AKT expression are associated with triple negative breast cancer development and clinical outcome

2015 · D. Marchion, R. Ismail-Khan, et al. · Gynecologic Oncology

The BCL2 antagonist of cell death (BAD) signaling pathway and phospho-BAD protein levels are associated with triple-negative breast cancer clinical development and clinical outcome

2014 · D. Marchion, Y. Xiong, et al. · Gynecologic Oncology

BCL2 antagonist of cell death (BAD) gene sequence and functional analysis of phosphorylation sites in ovarian cancer

2014 · N. Bou Zgheib, Y. Xiong, et al. · Gynecologic Oncology

MK2206, a selective AKT inhibitor, modulates ovarian cancer cell line sensitivity to carboplatin plus paclitaxel

2012 · N. Bou Zgheib, D. Marchion, et al. · Gynecologic Oncology

The BAD apoptosis pathway is associated with carcinogenesis in a range of human tissue types

2012 · X. Stickles, D. Marchion, et al. · Gynecologic Oncology

Expression of metastasis-associated gene products and liver metastases in pancreatic endocrine tumors

2009 · J. Helm, J. Strosberg, et al. · Journal of Clinical Oncology

Primary gastroenteropancreatic poorly differentiated neuroendocrine carcinoma: Clinico-pathologic analysis of 68 cases

2009 · M. H. Bukhari, E. Byron, et al. · Journal of Clinical Oncology

Works count: 18

Citation count: 396

H-index: 6

I10-index: 6